Wall Street Zen Upgrades Nutex Health (NASDAQ:NUTX) to "Buy"

Key Points

• Wall Street Zen upgraded Nutex Health from “hold” to “buy.”
• Analysts overall rate the stock a “Moderate Buy,” with three Buy ratings and two Hold ratings and a consensus price target of $342.
• Nutex reported quarterly EPS of $5.71, above the $5.54 estimate, while revenue of $217.61 million also topped analyst expectations.

Nutex Health (NASDAQ:NUTX - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Saturday, Wall Street Zen reports.

Several other equities analysts have also commented on NUTX. B. Riley Financial upped their price target on Nutex Health from $325.00 to $357.00 and gave the company a "buy" rating in a research note on Monday, November 9th. Ladenburg Thalmann & Co. Inc. initiated coverage on Nutex Health in a research report on Monday, October 26th. They set a "buy" rating and a $336.00 price objective for the company. Lake Street Capital boosted their price objective on shares of Nutex Health from $310.00 to $333.00 and gave the company a "buy" rating in a report on Monday, November 9th. Zacks Research cut shares of Nutex Health from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 6th. Finally, Weiss Ratings cut shares of Nutex Health from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Thursday. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Nutex Health currently has an average rating of "Moderate Buy" and a consensus target price of $342.00.

Nutex Health Trading Up 1.3%

NUTX opened at $173.67 on Friday. Nutex Health has a one year low of $83.99 and a one year high of $226.16. The stock has a market capitalization of $1.19 billion, a PE ratio of 7.32 and a beta of 0.66. The business's 50 day moving average price is $202.30 and its 200 day moving average price is $152.07. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 4.76.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $5.71 earnings per share for the quarter, topping the consensus estimate of $5.54 by $0.17. Nutex Health had a return on equity of 34.43% and a net margin of 20.68%. The company had revenue of $217.61 million during the quarter, compared to analyst estimates of $214.82 million. As a group, equities research analysts expect that Nutex Health will post 27.70 EPS for the current year.

Insider Transactions at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the firm's stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the transaction, the director owned 400 shares of the company's stock, valued at $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 44.68% of the stock is currently owned by company insiders.

Institutional Trading of Nutex Health

A number of large investors have recently modified their holdings of the stock. Kilter Group LLC purchased a new position in Nutex Health in the second quarter valued at $27,000. Allworth Financial LP acquired a new position in Nutex Health during the 2nd quarter worth $35,000. GK Wealth Management LLC purchased a new stake in Nutex Health during the 3rd quarter worth about $73,000. EverSource Wealth Advisors LLC purchased a new stake in Nutex Health during the 1st quarter worth about $83,000. Finally, Voya Investment Management LLC purchased a new stake in Nutex Health during the 3rd quarter worth about $206,000. Hedge funds and other institutional investors own 5.32% of the company's stock.

About Nutex Health

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company's chairman and chief executive officer, Nutex operates in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.